Latest Breaking News On - Specialty pharmaceuticals at alliance global partners on - Page 1 : comparemela.com

Share: NEW YORK, April 21, 2021 /PRNewswire/  Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that CEO Nadav Kidron will be featured in a live webinar titled Grand Rounds: a Webinar in Biotech and Specialty Pharma hosted by James Molloy, Managing Director of Equity Research, Biotechnology and Specialty Pharmaceuticals at Alliance Global Partners on Monday, April 26, 2021  at 11:00 Eastern.      Mr. Kidron, along with Premas Biotech Co-Founder and Managing Director Dr. Prabuddha Kundu, will discuss Oramed Pharmaceuticals oral insulin drug, currently in Phase 3 clinical trials, and the oral COVID-19 vaccine candidate of Oravax Medical Inc., which is 63% owned by Oramed Pharmaceuticals. Pre-clinical trials have shown that Oravax s oral vaccine candidate produces antibodies after a single dose and may potentially be a better candidate for

United statesNadav kidronPrabuddha kunduJames molloyEstee yaariOramed pharmaceuticals incCompany contactDrug administrationOramed pharmaceuticalsExchange commissionEquity researchSpecialty pharmaceuticals at alliance global partners onOravax medical incPremas biotech coGrand roundsSpecialty pharma